175 related articles for article (PubMed ID: 28256434)
1. Pathologic correlates of supranuclear gaze palsy with parkinsonism.
Martin WRW; Hartlein J; Racette BA; Cairns N; Perlmutter JS
Parkinsonism Relat Disord; 2017 May; 38():68-71. PubMed ID: 28256434
[TBL] [Abstract][Full Text] [Related]
2. Is Levodopa Response a Valid Indicator of Parkinson's Disease?
Martin WRW; Miles M; Zhong Q; Hartlein J; Racette BA; Norris SA; Ushe M; Maiti B; Criswell S; Davis AA; Kotzbauer PT; Cairns NJ; Perrin RJ; Perlmutter JS
Mov Disord; 2021 Apr; 36(4):948-954. PubMed ID: 33253432
[TBL] [Abstract][Full Text] [Related]
3. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
[TBL] [Abstract][Full Text] [Related]
5. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
Miki Y; Tsushima E; Foti SC; Strand KM; Asi YT; Yamamoto AK; Bettencourt C; Oliveira MCB; De Pablo-Fernández E; Jaunmuktane Z; Lees AJ; Wakabayashi K; Warner TT; Quinn N; Holton JL; Ling H
Brain; 2021 May; 144(4):1138-1151. PubMed ID: 33822892
[TBL] [Abstract][Full Text] [Related]
6. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia].
Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H
No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
[TBL] [Abstract][Full Text] [Related]
8. Autopsy-proven progressive supranuclear palsy in two siblings.
Tetrud JW; Golbe LI; Forno LS; Farmer PM
Neurology; 1996 Apr; 46(4):931-4. PubMed ID: 8780066
[TBL] [Abstract][Full Text] [Related]
9. The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson's disease (PD).
Swallow DMA; Counsell CE
J Neurol; 2023 Jul; 270(7):3464-3474. PubMed ID: 36971841
[TBL] [Abstract][Full Text] [Related]
10. Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.
Quattrone A; Morelli M; Vescio B; Nigro S; Le Piane E; Sabatini U; Caracciolo M; Vescio V; Quattrone A; Barbagallo G; Stanà C; Nicoletti G; Arabia G; Nisticò R; Novellino F; Salsone M
Mov Disord; 2019 Apr; 34(4):487-495. PubMed ID: 30759325
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
[TBL] [Abstract][Full Text] [Related]
12. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
[TBL] [Abstract][Full Text] [Related]
13. MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism.
Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stamboulis E; Kapaki E
AJNR Am J Neuroradiol; 2018 Jun; 39(6):1047-1051. PubMed ID: 29622555
[TBL] [Abstract][Full Text] [Related]
14. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
[TBL] [Abstract][Full Text] [Related]
15. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
[TBL] [Abstract][Full Text] [Related]
16. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
[TBL] [Abstract][Full Text] [Related]
17. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
18. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Caparros-Lefebvre D; Elbaz A
Lancet; 1999 Jul; 354(9175):281-6. PubMed ID: 10440304
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.
Turcano P; Mielke MM; Josephs KA; Bower JH; Parisi JE; Boeve BF; Savica R
Mov Disord; 2017 Oct; 32(10):1439-1446. PubMed ID: 28843020
[TBL] [Abstract][Full Text] [Related]
20. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.
Koga S; Josephs KA; Ogaki K; Labbé C; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Aoki N; Rademakers R; Wszolek ZK; Ross OA; Dickson DW
Mov Disord; 2016 May; 31(5):653-62. PubMed ID: 26841329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
